The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis
Abstract
Subsequent to demyelination in multiple sclerosis, myelin repair occurs but, as lesions age, the ability to remyelinate diminishes. Molecular pathways underlying oligodendrocyte behaviour during CNS remyelination remain to be elucidated. In this study, we report for the first time constitutive expression of the CXC/alpha chemokine receptors, CXCR1, CXCR2 and CXCR3, on oligodendrocytes in normal adult human CNS tissue, the levels of which were upregulated in multiple sclerosis and other neurological diseases (OND). In addition, both immature (A2B5+/O4+) and more mature (CNPase+) human oligodendrocytes in vitro expressed the same three receptors. The respective ligands to CXCR1, CXCR2 and CXCR3 [i.e. CXCL8/IL-8, CXCL1/GRO-alpha and CXCL10/IP-10), were absent in CNS tissue from normals and subjects with OND, but were present at high levels on hypertrophic (reactive) astrocytes at the edge of active (but not silent) multiple sclerosis lesions. Astrocytes in vitro could be induced to express chemokines following stimulation with pro-inflammatory cytokines. CXCL8 and CXCL1 production by human astrocytes at both the RNA and protein levels could be induced by interleukin (IL)-1beta, while CXCL10 was induced by both IL-1beta and interferon-gamma. Since these cytokines are integral to inflammatory events occurring at the margins of active multiple sclerosis lesions, their upregulation in these regions may underlie the dynamics of chemokine expression observed herein. The simultaneous expression of different CXC chemokine receptors on oligodendrocytes, and their ligands on astrocytes around multiple sclerosis lesions, may bespeak novel functional roles for these immune system molecules in the recruitment of oligodendrocytes and remyelination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cole, K. E., Strick, C. A., Paradis, T. J., Ogborne, K. T., Loetscher, M., Gladue, R. P., Lin, W., Boyd, J. G., Moser, B., Wood, D. E., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.12.2009 · Cited by 870
Izikson, L., Klein, R. S., Charo, I. F., Weiner, H. L., & Luster, A. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1075 · Cited by 584
Multiple sclerosis: Remyelination of nascent lesions: Remyelination of nascent lesions
Prineas, J. W., Barnard, R. O., Kwon, E. E., Sharer, L. R., & Cho, E. ‐. (1993) · Annals of Neurology · doi:10.1002/ana.410330203 · Cited by 574 · cited 1×
“Despite the presence of OPCs (Scolding et al., 1998; Chang et al., 2000; Maeda et al., 2001; Wolswijk, 2002), remyelination in multiple sclerosis is usually limited in extent (Prineas et al., 1993; Raine and Wu, 1993; Franklin, 2002).”
BackgroundAccuracy and calibration of commercial oligonucleotide and custom cDNA microarrays
Yuen, T. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e48 · Cited by 520
Cc Chemokine Receptor 2 Is Critical for Induction of Experimental Autoimmune Encephalomyelitis
Fife, B. T., Huffnagle, G. B., Kuziel, W. A., & Karpus, W. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.6.899 · Cited by 511 · cited 3×
“, 2002), while CCL2/MCP-1, CCL3 and CCL5 are important in recruitment of macrophages via interactions with CCR1, CCR2 and CCR5 (Fife et al., 2000; Izikson et al., 2000; Huang et al., 2001; Trebst et al., 2001).”
BackgroundKarpus, W. J., Lukacs, N. W., McRae, B. L., Strieter, R. M., Kunkel, S. L., & Miller, S. D. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.10.5003 · Cited by 482
Trebst, C., Lykke Sørensen, T., Kivisäkk, P., Cathcart, M. K., Hesselgesser, J., Horuk, R., Sellebjerg, F., Lassmann, H., & Ransohoff, R. M. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63017-9 · Cited by 242
Meeuwsen, S., Persoon‐Deen, C., Bsibsi, M., Ravid, R., & Noort, J. M. V. (2003) · Glia · doi:10.1002/glia.10259 · Cited by 185
Cited by
Multiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740
Self-citationAstrocyte Crosstalk in CNS Inflammation
Linnerbauer, M., Wheeler, M. A., & Quintana, F. J. (2020) · Neuron · doi:10.1016/j.neuron.2020.08.012 · Cited by 989
“Oligodendrocytes also secrete the pro-inflammatory cytokines IL-1β, CCL-2, IL-17 and IL-6 (Moyon et al., 2015; Ramesh et al., 2012; Tzartos et al., 2008), which induce NF-κB signaling and pro-inflammatory functions in astrocytes (Fig.”
BackgroundOligodendrocyte‐microglia cross‐talk in the central nervous system
Peferoen, L., Kipp, M., van der Valk, P., van Noort, J. M., & Amor, S. (2014) · Immunology · doi:10.1111/imm.12163 · Cited by 438
Oligodendrocyte, Astrocyte, and Microglia Crosstalk in Myelin Development, Damage, and Repair
Domingues, H. S., Portugal, C. C., Socodato, R., & Relvas, J. B. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00071 · Cited by 432
Chemokines and Chemokine Receptors: Standing at the Crossroads of Immunobiology and Neurobiology
Ransohoff, R. M. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.010 · Cited by 371
Oligodendrocyte development and the onset of myelination in the human fetal brain
Jakovcevski, I. (2009) · Frontiers in Neuroanatomy · doi:10.3389/neuro.05.005.2009 · Cited by 323
“Moreover, it has been demonstrated that this chemokine is upregulated during experimental autoimmune encephalomyelitis (EAE) (Glabinski et al., 2000) and around lesions in multiple sclerosis (Filipovic et al., 2002, 2003; Omari et al., 2005, 2006).”
BackgroundStuart, M. J., & Baune, B. T. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.001 · Cited by 259
Kölliker-Frers, R., Udovin, L., Otero-Losada, M., Kobiec, T., Herrera, M. I., Palacios, J., Razzitte, G., & Capani, F. (2021) · Mediators of Inflammation · doi:10.1155/2021/9999146 · Cited by 258
“A wide range of proin-fl ammatory cytokines, including IL 1, 2, and 3, IFN α , β , and γ , TNF-α , and lymphotoxin, released by microglia, have been detected in demyelinating pathologies like MS, suggesting that microglial activity and oligodendrocyte damage may be associated [116, 117].”
Zhang, Z.-J., Cao, D.-L., Zhang, X., Ji, R.-R., & Gao, Y.-J. (2013) · Pain · doi:10.1016/j.pain.2013.07.002 · Cited by 254
CXCR2 antagonists for the treatment of pulmonary disease
Chapman, R. W., Phillips, J. E., Hipkin, R. W., Curran, A. K., Lundell, D., & Fine, J. S. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.10.005 · Cited by 214
Control of autoimmune CNS inflammation by astrocytes
Rothhammer, V., & Quintana, F. J. (2015) · Seminars in Immunopathology · doi:10.1007/s00281-015-0515-3 · Cited by 214
Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders
Stuart, M. J., Singhal, G., & Baune, B. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00357 · Cited by 163
Inflammatory cytokines influence measures of white matter integrity in Bipolar Disorder
Benedetti, F., Poletti, S., Hoogenboezem, T. A., Mazza, E., Ambrée, O., de Wit, H., Wijkhuijs, A. J. M., Locatelli, C., Bollettini, I., Colombo, C., et al. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.047 · Cited by 151
CXCL10 Triggers Early Microglial Activation in the Cuprizone Model
Clarner, T., Janssen, K., Nellessen, L., Stangel, M., Skripuletz, T., Krauspe, B., Hess, F.-M., Denecke, B., Beutner, C., Linnartz-Gerlach, B., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401459 · Cited by 150
Dulamea, A. O. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-47861-6_7 · Cited by 128
Baxi, E. G., DeBruin, J., Tosi, D. M., Grishkan, I. V., Smith, M. D., Kirby, L. A., Strasburger, H. J., Fairchild, A. N., Calabresi, P. A., & Gocke, A. R. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3817-14.2015 · Cited by 103
“…the presence of inflammatory cytokines in MS lesions has been demonstrated to result in increased expression of chemokine receptors, including CXCR1, CXCR2, and CXCR3, on oligodendrocytes, which in turn affects their migration and recruitment during the remyelination process (Omari et al., 2005).”
Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures
De Paola, M., Buanne, P., Biordi, L., Bertini, R., Ghezzi, P., & Mennini, T. (2007) · NeuroImmunoModulation · doi:10.1159/000123834 · Cited by 47
Accelerated Prion Replication in, but Prolonged Survival Times of, Prion-Infected CXCR3−/−Mice
Riemer, C., Schultz, J., Burwinkel, M., Schwarz, A., Mok, S. W. F., Gültner, S., Bamme, T., Norley, S., van Landeghem, F., Lu, B., et al. (2008) · Journal of Virology · doi:10.1128/jvi.01371-08 · Cited by 45
Secretome Analysis of Human Oligodendrocytes Derived from Neural Stem Cells
Kim, W. K., Kim, D., Cui, J., Jang, H. H., Kim, K. S., Lee, H. J., Kim, S. U., & Ahn, S.-M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084292 · Cited by 34
“B GCP-2 CXCL6 R, Q NA (CXCR2 ligand) [48]”
BackgroundRepeated ethanol treatment in adolescent rats alters cortical NMDA receptor
Sircar, R., & Sircar, D. (2006) · Alcohol · doi:10.1016/j.alcohol.2006.07.002 · Cited by 32
Maysami, S., Nguyen, D., Zobel, F., Heine, S., Höpfner, M., & Stangel, M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.05.021 · Cited by 25
“However, very recent in vivo studies also revealed the expression of certain chemokine receptors on human oligodendrocytes (Filipovic et al, 2003; Omari et al., 2005; Omari et al., 2006) in health and disease.”
Background
Metadata
- Authors
- Omari, K. M., John, G. R., Sealfon, S. C., & Raine, C. S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-03-17
- Volume
- 128
- Issue
- 5
- Pages
- 1003-1015
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2021941118
- Cited by
- 196
- References
- 8
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.